FHIT and idiopathic pulmonary fibrosis: However, loss of heterozygosity, homozygous deletions, and abnormal expression of the human fragile histidine triad (FHIT) tumor suppressor gene have been described in NSCLC, particularly in SCCs and in smokers, and in metaplastic areas and bronchiolar epithelia of IPF patients [51].